FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileElevance Health Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ELV
Elevance Health Inc. Stock AnalysisComprehensive stock analysis for Elevance Health Inc. (ELV) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisELV
ELV
Elevance Health Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ELV
  1. Home
  2. Stocks
  3. Elevance Health Inc.

Elevance Health Inc.

🇺🇸ELV•NYSE

Elevance Health Inc.

🇺🇸ELV•NYSE
Market cap
$96.42B
Sentiment

Your view on ELV

Mkt Cap
$96.42B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Elevance Health Inc.

Industry
Medical - Healthcare Plans
Sector
Healthcare
CEO
Gail Koziara Boudreaux
Headquarters
220 Virginia Avenue, Indianapolis, IN, US
Industry
Medical - Healthcare Plans
Sector
Healthcare
CEO
Gail Koziara Boudreaux
Headquarters
220 Virginia Avenue, Indianapolis, IN, US
Description

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.

The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Elevance Health Inc. from FRC's valuation model, read against the market price. ELV last traded at $446.28, 19.0× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Elevance Health Inc.. Starting points for Elevance Health Inc.: P/E 19.0, EPS $23.62, beta 0.71 — an Medical - Healthcare Plans name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Elevance Health Inc.. Elevance Health Inc. paid $6.87 per share over the last year — a 1.5% yield at the current $446.28 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Elevance Health Inc.. Trailing twelve-month EPS for Elevance Health Inc. stands at $23.62. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$463.50

average of 22 firms, last 12 months

 

$463.50

Low $391.00

Median $474.00

High $523.00

 

Analyst Ratings

Buy19 firms, last 12 months
  • Strong Buy0
  • Buy14
  • Hold5
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$2.08$12.41$29.05$30.25
Low estimate$1.78$9.18$27.33$29.35
High estimate$2.79$14.21$29.78$31.14
No. of analysts14111312
Year-ago EPS$3.33$12.58$25.12—
Growth-37.5%-1.4%+15.6%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$49.38B$50.53B$200.07B$205.03B
Low estimate$47.69B$48.78B$196.11B$195.41B
High estimate$51.18B$53.30B$204.31B$215.30B
No. of analysts1081112
Year-ago revenue$49.75B$50.18B$199.13B—
Growth-0.7%+0.7%+0.5%—
Recent analyst actions15 rating and price-target changes, latest Nov 18, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Elevance Health Inc.. Elevance Health Inc. has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ELV13 companies · 8 funds
Compare ELV with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ALHCAlignment Healthcare, Inc.Medical - Healthcare Plans$1.6B
  • CIThe Cigna GroupMedical - Healthcare Plans$79.1B
  • CNCCentene CorporationMedical - Healthcare Plans$37.0B
  • CVSCVS Health CorporationMedical - Healthcare Plans$113.3B
  • HUMHumana Inc.Medical - Healthcare Plans$55.4B
  • MOHMolina Healthcare, Inc.Medical - Healthcare Plans$12.2B
  • OSCROscar Health, Inc.Medical - Healthcare Plans$8.1B
  • UNHUnitedHealth Group IncorporatedMedical - Healthcare Plans$369.2B

More Medical - Healthcare Plans companies

  • UNH.NEUnitedHealth Group IncNEO
  • CLOVClover Health Investments, Corp.NASDAQ$2.6B
  • IHGPJun An Kang Group Inc.OTC$10M
  • MRAIMarpai, Inc.OTC$9M
  • PFHOPacific Health Care Organization, Inc.OTC$17M

ETFs holding Elevance Health Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.14%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.12%
  • IVViShares Core SP 500 ETF$852.9B in assets0.15%
  • SPYState Street SPDR S&P 500 ETF Trust$818.5B in assets0.15%
  • IHFiShares US Healthcare Providers ETF$1.5B in assets9.75%
  • HHL.TOHarvest Healthcare Leaders Income ETF$2.2B in assets4.83%
  • IONProShares - S&P Global Core Battery Metals ETF$8M in assets2.82%
  • FEGEFirst Eagle Global Equity ETF$2.7B in assets1.89%

Largest holders first, then the funds most concentrated in ELV.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Elevance Health Inc., and how their positions are changing. At a $96.42B market value, institutional positions materially move Elevance Health Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Elevance Health Inc. executives and directors. Shares of Elevance Health Inc. have traded between $273.71 and $458.75 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Elevance Health Inc.. Elevance Health Inc. is a $96.42B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Elevance Health Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Elevance Health Inc.. Coverage tracks Elevance Health Inc. within Medical - Healthcare Plans (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Elevance Health Inc.

ELV Analysis
Good
Past5
Growth4
Health3
Profit3
Value2

News

Latest Market News